Silver-Coated Distal Femur Megaprosthesis in Chronic Infections with Severe Bone Loss: A Multicentre Case Series
Michele Fiore(Università Campus Bio-Medico), Massimiliano De Paolis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Luca Cevolani(Istituto Ortopedico Rizzoli), Sara Tedeschi(University of Bologna), Stefania Claudia Parisi(Azienda USL di Bologna), Domenico Andrea Campanacci(Azienda Ospedaliero-Universitaria Careggi), Marta Bortoli(Azienda USL di Bologna), Pierluigi Viale(Azienda USL di Bologna), Eleonora Zamparini(University of Bologna), Lorenzo Morante(Azienda USL di Bologna), Andrea Sambri(Azienda USL di Bologna), Davide María Donati(University of Modena and Reggio Emilia), Maria Pia Neri(Herat University), Francesco Panzavolta(Azienda USL di Bologna), Domenico Alesi(Orthopedic Institute), Stefano Zaffagnini(Istituto Ortopedico Rizzoli)
Cited by 7
Related Papers
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404